Osteoporosis: Therapeutic Options
The definition of osteoporosis was originally formulated at a conference of the World Health Organization (WHO) in 1993 as ‘a systemic skeletal disease characterized by decreased bone mass and altered micro-architecture of bone tissue, leading to enhanced bone fragility and risk of fractures’. Osteo...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Pensoft Publishers
2015-12-01
|
Series: | Folia Medica |
Subjects: | |
Online Access: | http://www.degruyter.com/view/j/folmed.2015.57.issue-3-4/folmed-2015-0037/folmed-2015-0037.xml?format=INT |
id |
doaj-b75d1eb7b12340809bbaa3c61d7599de |
---|---|
record_format |
Article |
spelling |
doaj-b75d1eb7b12340809bbaa3c61d7599de2020-11-25T01:32:38ZengPensoft PublishersFolia Medica 1314-21432015-12-01573-418119010.1515/folmed-2015-0037folmed-2015-0037Osteoporosis: Therapeutic OptionsIvanova Stefka0Vasileva Liliya1Ivanova Stanislava2Peikova Lily3Obreshkova Danka4Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Medical University Sofia, Bulgaria Department of Pharmacology and Clinical Pharmacology, Faculty of Pharmacy, Medical University Plovdiv, Bulgaria, 15A Vassil Aprilov Blvd., 4002 Plovdiv, Bulgaria Department of Pharmacognosy and Pharmaceutical Chemistry, Faculty of Pharmacy, Medical University Plovdiv, Bulgaria Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Medical University Sofia, Bulgaria Department of Pharmacognosy and Pharmaceutical Chemistry, Faculty of Pharmacy, Medical University Plovdiv, Bulgaria The definition of osteoporosis was originally formulated at a conference of the World Health Organization (WHO) in 1993 as ‘a systemic skeletal disease characterized by decreased bone mass and altered micro-architecture of bone tissue, leading to enhanced bone fragility and risk of fractures’. Osteoporosis is characterized by low bone mineral density (BMD) and loss of the structural and bio-mechanical properties that are required to maintain bone homeostasis. This review aims to address the currently available options in prevention and treatment of osteoporosis. Management of osteoporosis includes non-pharmacological treatment - diet rich of calcium and vitamin D, healthy lifestyle, proper exercise plan, and pharmacological therapy. Combination of non-pharmacological and pharmacological treatment options have to be considered for prevention of osteoporosis and minimization of the risk of fractures. Given the heterogeneity of osteoporosis syndrome and lack of significant number of comparative studies, the choice of a pharmacological agents should be individualized.http://www.degruyter.com/view/j/folmed.2015.57.issue-3-4/folmed-2015-0037/folmed-2015-0037.xml?format=INTosteoporosistreatmentpreventionpharmacologystructure-activity |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Ivanova Stefka Vasileva Liliya Ivanova Stanislava Peikova Lily Obreshkova Danka |
spellingShingle |
Ivanova Stefka Vasileva Liliya Ivanova Stanislava Peikova Lily Obreshkova Danka Osteoporosis: Therapeutic Options Folia Medica osteoporosis treatment prevention pharmacology structure-activity |
author_facet |
Ivanova Stefka Vasileva Liliya Ivanova Stanislava Peikova Lily Obreshkova Danka |
author_sort |
Ivanova Stefka |
title |
Osteoporosis: Therapeutic Options |
title_short |
Osteoporosis: Therapeutic Options |
title_full |
Osteoporosis: Therapeutic Options |
title_fullStr |
Osteoporosis: Therapeutic Options |
title_full_unstemmed |
Osteoporosis: Therapeutic Options |
title_sort |
osteoporosis: therapeutic options |
publisher |
Pensoft Publishers |
series |
Folia Medica |
issn |
1314-2143 |
publishDate |
2015-12-01 |
description |
The definition of osteoporosis was originally formulated at a conference of the World Health Organization (WHO) in 1993 as ‘a systemic skeletal disease characterized by decreased bone mass and altered micro-architecture of bone tissue, leading to enhanced bone fragility and risk of fractures’. Osteoporosis is characterized by low bone mineral density (BMD) and loss of the structural and bio-mechanical properties that are required to maintain bone homeostasis. This review aims to address the currently available options in prevention and treatment of osteoporosis. Management of osteoporosis includes non-pharmacological treatment - diet rich of calcium and vitamin D, healthy lifestyle, proper exercise plan, and pharmacological therapy. Combination of non-pharmacological and pharmacological treatment options have to be considered for prevention of osteoporosis and minimization of the risk of fractures. Given the heterogeneity of osteoporosis syndrome and lack of significant number of comparative studies, the choice of a pharmacological agents should be individualized. |
topic |
osteoporosis treatment prevention pharmacology structure-activity |
url |
http://www.degruyter.com/view/j/folmed.2015.57.issue-3-4/folmed-2015-0037/folmed-2015-0037.xml?format=INT |
work_keys_str_mv |
AT ivanovastefka osteoporosistherapeuticoptions AT vasilevaliliya osteoporosistherapeuticoptions AT ivanovastanislava osteoporosistherapeuticoptions AT peikovalily osteoporosistherapeuticoptions AT obreshkovadanka osteoporosistherapeuticoptions |
_version_ |
1725080821150253056 |